Paul S. Donnelly

Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation

Peter J. Crouch, Lin W. Hung, Paul A. Adlard et al. · Proceedings of the National Academy of Sciences · 2009 · 271 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

Yining Huang, Richard I. Lindley, Xiaoying Chen et al. · The Lancet · 2019 · 271 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Comparison of ⁶⁴Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and <i>in Vitro</i>/<i>in Vivo</i> Stability

Maggie Cooper, Kavitha Sunassee, Karen Shaw et al. · Bioconjugate Chemistry · 2012 · 214 citations · Full text

Medicine, Immunology, Pharmacology +17

Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

Blaine R. Roberts, Nastasia K.-H. Lim, Erin J. McAllum et al. · Journal of Neuroscience · 2014 · 205 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Selective Intracellular Release of Copper and Zinc Ions from Bis(thiosemicarbazonato) Complexes Reduces Levels of Alzheimer Disease Amyloid-β Peptide

Paul S. Donnelly, Aphrodite Caragounis, Tai Du et al. · Journal of Biological Chemistry · 2007 · 194 citations · Full text

Natural Sciences, Chemistry, Neuroscience +14